Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes

被引:16
作者
Deiss, Dorothee
Kordonouri, Olga
Hartmann, Reinhard
Hopfenmueller, Werner
Luepke, Kerstin
Danne, Thomas
机构
[1] Humboldt Univ, Clin Gen Pediat, Otto Heubner Ctr, Charite, Berlin, Germany
[2] Childrens Hosp Bult, Hannover, Germany
[3] Free Univ Berlin, Dept Biometr, Inst Med Informat Biometr & Epidemiol, Charite, D-1000 Berlin, Germany
关键词
CGMS; children; diabetes; hypoglycemia; IG;
D O I
10.1111/j.1399-5448.2007.00252.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Unsatisfactory basal insulin substitution may lead to asymptomatic hypoglycemia in children and adolescents with type 1 diabetes (T1D). To investigate the effects of multiple daily injections before and after changing to insulin glargine (IG), continuous glucose monitoring system (CGMS) data were used to analyze glycemic control and hypoglycemic episodes during the two different therapy regimens. Methods: Basal insulin therapy was changed to one daily injection of IG in 30 pediatric patients with T1D (14 boys and 16 girls; age 4.5-18.3 yr, median 14.2 yr; diabetes duration 0.5-15.6 yr, median 4.6 yr) having elevated fasting glucose or recurrent hypoglycemia despite treatment with multiple injection therapy (basal insulin: two to four injections of neutral protamine Hagedorn (NPH) and/or zinc lente insulin). Ambulatory CGMS was applied before and 6-8 wk after treatment change. Frequency of hypoglycemic and hyperglycemic episodes, glucose area under the curve (AUC), and time below 60 mg/dL and above 180 mg/dL, respectively, were calculated from CGMS data during the day (8:00-22:00 hours) and at night (22:00-8:00 hours). Results: Nocturnal hypoglycemia was detected by CGMS in 20 patients before and in 12 patients after the change to IG (p = .039), whereas both, the number of nocturnal and diurnal hypoglycemic episodes, decreased not significantly from 41 to 36 (p = .758) and 48 to 28 (p = .055), respectively. AUC and time below 60 mg/dL as well as hemoglobin A1c (HbA1c) were not significantly different before and after the change to IG. Conclusions: Under treatment with IG, asymptomatic hypoglycemia was reduced without increase of HbA1c.
引用
收藏
页码:157 / 162
页数:6
相关论文
共 32 条
[21]   Nocturnal hypoglycaemia and sleep disturbances in young teenagers with insulin dependent diabetes mellitus [J].
Porter, PA ;
Byrne, G ;
Stick, S ;
Jones, TW .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (02) :120-123
[22]   A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes [J].
Raskin, P ;
Klaff, L ;
Bergenstal, R ;
Hallé, JP ;
Donley, D ;
Mecca, T .
DIABETES CARE, 2000, 23 (11) :1666-1671
[23]   Less hypoglycemia with insulin glargine in intensive insulin therapy for the 1 diabetes [J].
Ratner, RE ;
Hirsch, IB ;
Neifing, JL ;
Garg, SK ;
Mecca, TE ;
Wilson, CA .
DIABETES CARE, 2000, 23 (05) :639-643
[24]   Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens [J].
Rosenstock, J ;
Park, G ;
Zimmerman, J .
DIABETES CARE, 2000, 23 (08) :1137-1142
[25]   Intensive replacement of basal insulin on patients with type 1 diabetes given rapid-acting insulin analog at mealtime - A 3-month comparsion between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime [J].
Rossetti, P ;
Pampanelli, S ;
Fanelli, C ;
Porcellati, F ;
Costa, E ;
Torlone, E ;
Scionti, L ;
Bolli, GB .
DIABETES CARE, 2003, 26 (05) :1490-1496
[26]   Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes [J].
Schober, E ;
Schoenle, E ;
Van Dyk, J ;
Wernicke-Panten, K .
DIABETES CARE, 2001, 24 (11) :2005-2006
[27]   THE EFFECT OF INTENSIVE TREATMENT OF DIABETES ON THE DEVELOPMENT AND PROGRESSION OF LONG-TERM COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
SHAMOON, H ;
DUFFY, H ;
FLEISCHER, N ;
ENGEL, S ;
SAENGER, P ;
STRELZYN, M ;
LITWAK, M ;
WYLIEROSETT, J ;
FARKASH, A ;
GEIGER, D ;
ENGEL, H ;
FLEISCHMAN, J ;
POMPI, D ;
GINSBERG, N ;
GLOVER, M ;
BRISMAN, M ;
WALKER, E ;
THOMASHUNIS, A ;
GONZALEZ, J ;
GENUTH, S ;
BROWN, E ;
DAHMS, W ;
PUGSLEY, P ;
MAYER, L ;
KERR, D ;
LANDAU, B ;
SINGERMAN, L ;
RICE, T ;
NOVAK, M ;
SMITHBREWER, S ;
MCCONNELL, J ;
DROTAR, D ;
WOODS, D ;
KATIRGI, B ;
LITVENE, M ;
BROWN, C ;
LUSK, M ;
CAMPBELL, R ;
LACKAYE, M ;
RICHARDSON, M ;
LEVY, B ;
CHANG, S ;
HEINHEINEMANN, M ;
BARRON, S ;
ASTOR, L ;
LEBECK, D ;
BRILLON, D ;
DIAMOND, B ;
VASILASDWOSKIN, A ;
LAURENZI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :977-986
[28]  
Tsalikian E, 2004, DIABETES CARE, V27, P722
[29]   INDUCTION OF HYPOGLYCEMIA UNAWARENESS BY ASYMPTOMATIC NOCTURNAL HYPOGLYCEMIA [J].
VENEMAN, T ;
MITRAKOU, A ;
MOKAN, M ;
CRYER, P ;
GERICH, J .
DIABETES, 1993, 42 (09) :1233-1237
[30]   Glycemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple daily injections vs continuous subcutaneous insulin infusion [J].
Weintrob, N ;
Schechter, A ;
Benzaquen, H ;
Shalitin, S ;
Lilos, P ;
Galatzer, A ;
Phillip, M .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2004, 158 (07) :677-684